[HTML][HTML] Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression

…, P Hufnagl, N Zerbe, A Meyer, J Aouizerate… - The American Journal of …, 2016 - Elsevier
The anti-melanoma differentiation-associated gene 5 (MDA5) autoantibody is specifically
associated with dermatomyositis (DM). Nevertheless, anti–MDA5 + -patients experience …

[HTML][HTML] Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy

J Aouizerate, M De Antonio, G Bassez… - Acta neuropathologica …, 2014 - Springer
Objectives To assess the value of major histocompatibility complex (MHC) class II antigen (HLA-DR)
expression to distinguish anti-synthetase myopathy (ASM) from dermatomyositis (…

Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis

C Gitiaux, M De Antonio, J Aouizerate… - …, 2016 - academic.oup.com
Objective. Outcome of JDM is highly heterogeneous. Our objective was to determine clinical
and muscle biopsy features associated with poor outcome and response to treatment. …

Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis

J Aouizerate, M De Antonio, B Bader-Meunier… - …, 2018 - academic.oup.com
Objectives Myositis-specific autoantibodies (MSAs) are increasingly used to delineate
distinct subgroups of JDM. The aim of our study was to explore without a priori hypotheses …

Distinct interferon signatures stratify inflammatory and dysimmune myopathies

M Rigolet, C Hou, YB Amer, J Aouizerate, B Periou… - RMD open, 2019 - rmdopen.bmj.com
Objective The role of interferons (IFN) in the pathophysiology of primary inflammatory and
dysimmune myopathies (IDM) is increasingly investigated, notably because specific …

[HTML][HTML] Clinical features in patients with long-lasting macrophagic myofasciitis

M Rigolet, J Aouizerate, M Couette… - Frontiers in …, 2014 - frontiersin.org
Macrophagic myofasciitis (MMF) is an emerging condition characterized by specific muscle
lesions assessing abnormal long-term persistence of aluminum hydroxide within …

Renal transplantation in patients with sarcoidosis: a French multicenter study

J Aouizerate, M Matignon, N Kamar… - Clinical Journal of the …, 2010 - journals.lww.com
Background and objectives: Sarcoidosis is a multisystem disorder of unknown etiology. The
outcome of renal transplantation on patients with sarcoidosis is not well known. A few case …

Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation

…, S Homs, P Remy, J Aouizerate… - Transplant …, 2012 - Wiley Online Library
Preventive treatment of focal and segmental glomerusclerosis (FSGS) allograft recurrence
in high risk recipients having a prior history of graft loss caused by FSGS recurrence is still a …

[HTML][HTML] Acute liver failure following a single dose of Atezolizumab, as assessed for causality using the updated RUCAM

R Tzadok, S Levy, J Aouizerate… - Case Reports in …, 2022 - hindawi.com
Immune checkpoint inhibitors have become major therapeutic agents in oncology over the
last few years. However, they are associated with a variety of potentially severe autoimmune …

Kidney transplantation in patients with inflammatory bowel diseases (IBD): analysis of transplantation outcome and IBD activity

…, I Nachmany, N Lubezky, J Aouizerate… - Transplant …, 2019 - Wiley Online Library
Inflammatory bowel diseases ( IBD ) is a systemic disorder with possible renal involvement,
yet data regarding the outcome of kidney transplantation ( KT ) in those patients, and IBD …